Skip to main content

Peer Review reports

From: A novel intergenic region (chr2: 30,193,816)-ALK fusion shows sensitivity to Alectinib in lung adenocarcinoma

Original Submission
4 Nov 2022 Submitted Original manuscript
20 Dec 2022 Reviewed Reviewer Report
5 Jan 2023 Reviewed Reviewer Report
22 Jan 2023 Author responded Author comments - Rui Liu
25 Jan 2023 Reviewed Reviewer Report
27 Jan 2023 Reviewed Reviewer Report
28 Jan 2023 Author responded Author comments - Rui Liu
Resubmission - Version 2
22 Jan 2023 Submitted Manuscript version 2
Publishing
2 Feb 2023 Editorially accepted
8 Feb 2023 Article published 10.1186/s12890-023-02351-5

You can find further information about peer review here.

Back to article page